1-(7-Bromo-3,4-dihydroisoquinolin-2(1H)-yl)-2,2,2-trifluoroethanone, 95.0%, 250mg

3-Bromo-4-methylpyridine, 98%, 100g

(BENZO[B]THIOPHEN-7-YL)METHANAMINE HCL, 95.0%, 250mg

(1R)-2-METHYL-1-(2-PYRIDYL)PROPYLAMINE, 95.0%, 250mg

2-(4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)piperidin-1-yl)acetic acid, 95.0%, 250mg

1,2-Dibromo-4-methyl-5-nitrobenzene, 95.0%, 5g

Benzoic acid ethyl ester, min. 99%, for synthesis, 2.5 l, glass packaging

2-Oxoglutaric Acid>99.0%(T)100g

2-Methyl-2-(pyridin-2-yl)propan-1-amine, 97%, 50mg

trans-1,4-Cyclohexanediol>97.0%(GC)1g

Glycosynthase (Endo-M-N175Q) Recombinant: from Mucor hiemalis expressed in Escherichia coli (100m units/vial)1vial

Na-Fmoc-Ne-Azido-D-Lysine, 99.0%, 1g

6-(4-Methoxybenzylcarbamoyl)pyridine-3-boronic acid, 96%, 5g